GELFOND RICHARD L 4
4 · IMAX CORP · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
IMAX CEO Richard Gelfond Exercises Options, Sells 121,220 Shares
What Happened
Richard L. Gelfond, CEO of IMAX Corp (IMAX), exercised stock options to acquire 121,220 common shares at $31.40 per share (total exercise cost $3,806,308) on March 10, 2026, and sold those 121,220 shares in the open market the same day at $40.10 per share for gross proceeds of $4,860,837. The transactions produced gross proceeds roughly $1,054,529 above the exercise cost (before taxes and fees). The Form 4 shows both the option-to-share conversion and the subsequent sale.
Key Details
- Transaction date: 2026-03-10. Form filed: 2026-03-12 (timely filing).
- Exercise (conversion of derivative): 121,220 shares acquired at $31.40 each — total cost $3,806,308.
- Open-market sale: 121,220 shares sold at $40.10 each — gross proceeds $4,860,837.
- Post-transaction holdings (per footnote): options outstanding 1,697,475; restricted share units 231,562; common shares 765,002.
- Footnotes: F1 states conversion occurred pursuant to a 10b5-1 plan (footnote lists plan date as December 9, 2026); F2–F3 note these were options issued in 2016 with vesting installments and an expiration date of June 7, 2026; F4 gives remaining balances after the transactions.
- Transaction codes: conversion is shown as derivative conversion (C); sale is an open-market disposition (S).
Context
- This was an exercise of previously granted options followed by an immediate sale of the resulting shares — effectively a cashless exercise/sale of newly acquired shares.
- Such transactions are often routine for executives exercising and selling vested options; they are factual disclosures of trading activity and not a direct statement of future company prospects.
Insider Transaction Report
Form 4
IMAX CORPIMAX
GELFOND RICHARD L
DirectorChief Executive Officer
Transactions
- Conversion
common shares
[F1]2026-03-10$31.40/sh+121,220$3,806,308→ 886,222 total - Sale
common shares
2026-03-10$40.10/sh−121,220$4,860,837→ 765,002 total - Conversion
stock options (to buy)
[F2][F3][F4]2026-03-10$31.40/sh−121,220$3,806,308→ 365,064 totalExercise: $31.40From: 2026-03-10Exp: 2026-06-07→ common shares (121,220 underlying)
Holdings
- 765,002
common shares (opening balance)
Footnotes (4)
- [F1]Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2026.
- [F2]These options were issued in 2016 and are set to expire on June 7, 2026.
- [F3]The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016.
- [F4]This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,697,475, 231,562 and 765,002, respectively.
Signature
/s/ Richard L. Gelfond|2026-03-12